Beta Bionic, Inc. (BBNX)
Beta Bionic will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Beta Bionic Revenue
Beta Bionic had revenue of $53.03M in the twelve months ending September 30, 2024. In the year 2023, Beta Bionic had annual revenue of $12.00M with 6,601.12% growth.
Revenue (ttm)
$53.03M
Revenue Growth
+6,601.12%
P/S Ratio
n/a
Revenue / Employee
$182,247
Employees
291
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 10 hours ago - Beta Bionics Aims For IPO To Cover Heavy Losses - Seeking Alpha
- 4 days ago - Insulin delivery device maker Beta Bionics files for a $100 million IPO - Renaissance Capital
- 4 days ago - Beta Bionics Files Registration Statement for Proposed Initial Public Offering - GLOBE NEWSWIRE
- 4 days ago - Beta Bionics IPO Registration Document (S-1) - SEC